Next |
home / stock / axsm / axsm message board
Subject | By | Source | When |
---|---|---|---|
$AXSM Price now last trade up | Frankestin | investorshub | 06/27/2023 11:05:09 PM |
$AXSM best news of the day | MiamiGent | investorshub | 06/26/2023 5:43:47 AM |
New mid term topic $100.00 by or before | georgejjl | investorshub | 06/23/2023 4:29:46 PM |
$AXSM what do you make of this data? | georgejjl | investorshub | 06/23/2023 3:51:48 PM |
Their target has been reached. Now what? | rosemountbomber | investorshub | 06/23/2023 12:11:48 PM |
we got news | georgejjl | investorshub | 06/21/2023 3:15:14 AM |
The now | georgejjl | investorshub | 06/21/2023 2:07:52 AM |
$AXSM When is this gonna take off? | chainma1l | investorshub | 06/18/2023 6:46:49 PM |
are we finally gonna see some action | MiamiGent | investorshub | 06/17/2023 10:52:22 AM |
$AXSM good read | Frankestin | investorshub | 06/17/2023 7:32:01 AM |
$AXSM Price now | georgejjl | investorshub | 06/15/2023 7:41:58 AM |
Price gaining | rosemountbomber | investorshub | 06/14/2023 5:10:03 PM |
short squeeze signal | rosemountbomber | investorshub | 06/13/2023 4:40:19 AM |
Morgan Stanleys price target of $90 for $AXSM | georgejjl | investorshub | 06/13/2023 2:47:17 AM |
$AXSM Do we have a winner?Turn around time? | chainma1l | investorshub | 06/11/2023 10:50:09 PM |
A rising star in the biotech industry | georgejjl | investorshub | 06/11/2023 11:58:50 AM |
what do you make of this data? | georgejjl | investorshub | 06/10/2023 6:02:45 PM |
great news | DewDiligence | investorshub | 06/09/2023 9:45:30 PM |
MomentumIts now last up | georgejjl | investorshub | 06/09/2023 6:18:48 PM |
$AXSM MomentumIts gaining last up | georgejjl | investorshub | 06/08/2023 6:53:49 AM |
News, Short Squeeze, Breakout and More Instantly...
Axsome Therapeutics Inc. Company Name:
AXSM Stock Symbol:
NASDAQ Market:
Axsome Therapeutics Inc. Website:
AXS-05 in Alzheimer's disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in poole...
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting effects of solriamfetol NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) --...
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering nove...